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Abstract: A marked increase in canine leptospirosis was observed in Switzerland over  
10 years with a peak incidence of 28.1 diagnosed cases/100,000 dogs/year in the most 
affected canton. With 95% affected dogs living at altitudes <800 m, the disease presented  
a seasonal pattern associated with temperature (r
2
 0.73) and rainfall (r
2
 0.39), >90% cases 
being diagnosed between May and October. The increasing yearly incidence however was 
only weakly correlated with climatic data including number of summer (r
2
 0.25) or rainy 
days (r
2
 0.38). Serovars Australis and Bratislava showed the highest seropositivity rates 
with 70.5% and 69.1%, respectively. Main clinical manifestations included renal (99.6%), 
pulmonary (76.7%), hepatic (26.0%), and hemorrhagic syndromes (18.2%), leading to  
a high mortality rate (43.3%). Similar to the human disease, liver involvement had the 
strongest association with negative outcome (OR 16.3). Based on these data, canine 
leptospirosis presents similar features and severity as the human infection for which it 
therefore can be considered a model. Its re-emergence in a temperate country with very 
high incidence rates in canines should thus be viewed as a warning and emphasize the need 
for increased awareness in other species.  
Keywords: leptospirosis; dog; zoonosis; climatic data; one health; renal failure;  
pulmonary hemorrhage 
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1. Introduction 
Leptospirosis is an emerging infectious disease of global importance [1,2]. Caused by spirochetes of 
the pathogenic genus Leptospira, it is considered one of the most widespread zoonoses worldwide [2]. 
Different wildlife species including small rodents, as well as domestic livestock and dogs, may act 
both as maintenance and incidental hosts of a variety of serovars. Animals may be maintenance hosts 
of some serovars, like the dog is a host of serovar Canicola, or become sick as incidental hosts of other 
serovars [1,2]. Small mammals are the most relevant maintenance hosts and vectors of infection for 
livestock, domestic pets and humans by shedding the bacteria through their urine [2]. Infection may 
occur from exposure to urine of carrier animals either directly or via contamination of soil or water [1]. 
Important risk factors for zoonotic transmission of leptospires therefore include both environmental 
factors and human interactions with wildlife and companion animals [2]. Warm and humid conditions 
favor a longer survival of leptospires in the environment, resulting in a higher incidence of human 
leptospirosis in the tropics, and peak incidence in summer and fall in more temperate regions [1,2]. 
Similar findings are reported from veterinary medicine, where seasonal peaks of clinical disease 
correlate with local temperature and rainfall patterns [3]. Indirect transmission through water sources 
contaminated with infected urine is likely one of the major routes of infection of humans exposed 
during water-related recreational and occupational activities. Adventure travelers and sportsmen 
returning from tropical regions therefore account for at least part of cases of clinical disease in 
industrialized countries [4]. In central European countries, autochthonous leptospirosis has been 
reported with an incidence rate of 1.26 per 100,000 inhabitants per year in a study from South-East 
Austria [5,6]. The authors hypothesize further that a considerable number of clinical cases are not even 
reported due to diagnostic difficulties and lack of reporting compliance, and calculated incidences are 
likely underestimated. The most common reported risk factors for infection in this study included 
activities in the woods, wet areas, gardening, and exposure to rodents, while 18% of people had been 
in contact with dogs, 46% reported contact to mice and rats [5]. 
Several studies investigated the particular role of the dog as zoonotic vector. Seroprevalence of 
Leptospira spp. in seemingly healthy canines in different countries varied between 4.9% and  
35.2% [7–11] and renal carriage or urinary shedding was documented by PCR in 1.5%–8.0% of dogs 
from various origins [12–14]. A large discrepancy between the fast rising number of diseased canines 
and the rare autochthonous human cases has recently been noted in Switzerland [15–17]. Even humans 
with intensive and frequent contact with dogs only rarely develop clinical infections with leptospires. 
Barmettler et al. investigated the risk of zoonotic transmission from dogs with acute leptospirosis to 
their owners and to the staff of a veterinary hospital with a high caseload of leptospirosis. Seroreactivity 
to Leptospira serovars in this human population was not detected in any of the 91 tested subjects and 
zoonotic transmission under standard recommended hygiene conditions was therefore deemed 
uncommon [18]. Interestingly, to the authors’ knowledge no proven case of direct dog-to-human 
transmission has been reported in the literature, although anecdotal cases are occasionally cited. Most 
of the evidence for the role of the dog as a relevant vector of infection is indirect and based on 
serological profile analogy [13,19]. 
On the other side however, dogs frequently exposed to water and those spending a lot of time 
outdoors such as herding and hunting dogs have been shown to be at increased risk of infection, 
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similarly to humans [20,21]. This resemblance possibly argues more for a role of canines as victims of 
infection rather than culprits for its spread [19]. Furthermore, in view of the discrepant incidence of 
clinical disease between various species in some countries, we suggest that the dog may be an indicator 
of the presence of Leptospira interrogans in the environment [22]. 
The goals of this study include the description of leptospirosis as a re-emerging zoonotic disease in 
the canine population of Switzerland over a 10-year-period, and the evaluation of the effect of climatic 
factors on the changing incidence and the seasonality of the disease. We thereby wish to raise 
awareness for this potentially fatal zoonosis in the temperate areas. 
2. Experimental Section  
2.1. Data Collection 
The database of the Small Animal Teaching Hospital of the Vetsuisse Faculty of the University of 
Bern and the database of the Nephrology Group were searched for cases of dogs diagnosed with 
leptospirosis between January 2003 and December 2012. Signalment, presenting complaint, history, 
physical exam findings, laboratory results, and outcome data were extracted from the medical records. 
Only dogs with minimal datasets including complete medical records, hematology, biochemistry, and 
medical imaging were considered for inclusion. 
Signalment data were further obtained from the general hospital canine population (hospital 
database) and from the Swiss national registry for dogs (ANIS database, Animal Identity Service AG, 
Bern, Switzerland) for the purpose of comparing signalment parameters and cantonal distribution of 
the normal canine population.  
Biogeographic data used for the characterization of the cases were obtained from the Swiss Federal 
Office for the Environment. For simplification, bioregions were grouped in Jura, Plateau, and Alps. 
Monthly and yearly climatic data, including temperature, rainfall and derived parameters (number of 
rainy days, winter days, freezing days, summer days) were obtained from the Swiss Federal Statistical 
Office for the corresponding time period. 
2.2. Clinical and Laboratory Characterization 
A case of leptospirosis was defined based on consistent clinical presentation, including dogs with 
renal, hepatic, pulmonary or hemorrhagic manifestations, with laboratory confirmation [18,23,24]. The 
latter could be obtained with either paired microscopic agglutination test (MAT) serology; single 
sample MAT serology; canine IgM ELISA; PCR on blood, urine, kidney or liver tissue; or consistent 
histopathology findings at necropsy [23].  
Dogs with leptospirosis were classified clinically based on organ involvement using standard 
criteria defined for the canine species. Renal involvement or acute kidney injury (AKI) was defined as 
the combination of acute uremic syndrome, renal azotemia and urinary parameters indicating kidney 
injury [25]. Dogs with any evidence of underlying chronic kidney disease (CKD) were only considered 
renal if they had evidence of acute exacerbation of otherwise stable disease. Severity of AKI was 
defined based on the described IRIS grading system [26]: mild AKI (corresponding to IRIS grades 1–3; 
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serum creatinine < 440 µmol/L), moderate AKI (corresponding to grade 4; serum creatinine  
440–880 µmol/L), and severe AKI (corresponding to grade 5; serum creatinine > 880 µmol/L). 
Hepatic involvement was defined as the presence of hepatic hyperbilirubinemia and arbitrarily 
considered relevant with serum bilirubin ≥ 10 µmol/L (normal: 0.5–4.0 µmol/L). It was further 
classified as mild for serum bilirubin 10–20 µmol/L and severe for bilirubin > 30 µmol/L [24,27]. 
Pulmonary involvement was defined as clinical evidence of relevant pulmonary disease causing 
labored breathing or dyspnea and/or radiographic evidence of moderate to severe peribronchial, 
interstitial or alveolar infiltrates [28–31]. Dogs with rapid resolution of pulmonary signs after 
correction of fluid overload, indicating iatrogenic pulmonary edema, were not considered to have the 
severe pulmonary form of leptospirosis (SPFL). Hemorrhagic syndrome (typically disseminated 
intravascular coagulopathy, DIC) was diagnosed in dogs with at least two abnormal parameters from 
the four routinely performed tests (platelet count, prothrombin time, activated partial thromboplastin 
time, and plasma fibrinogen concentration) [23].  
Serology with MAT was performed by the accredited National Reference Laboratory for 
Leptospirosis (Institute of Veterinary Bacteriology, National Center for Zoonoses, Bacterial Animal 
Diseases and Antimicrobial Resistance, Vetsuisse Faculty, University of Bern, Switzerland) according 
to the Guidelines of the World Health Organization International Leptospirosis Society [32]. Briefly, 
the MAT was performed using a panel of ubiquitous and locally prevalent serovars, including  
L. interrogans serovars Australis, Autumnalis, Bataviae, Bratislava, Canicola, Hardjo, 
Icterohaemorrhagiae, Pomona, Sejroe, and Tarassovi and L. kirschneri serovar Grippotyphosa. Sera 
were initially screened at a dilution of 1:100. Samples with a positive reaction were titrated in a serial 
two-fold dilution to a maximum of 1:3200 and the end-point titer was recorded. For case definition, 
paired serology with fourfold rise in sequential titers at a 1–3 weeks interval was considered  
first-choice. For animals where a second sample could not be obtained (typically due to early death),  
a single sample obtained at presentation with a titer ≥1:800 was considered positive, as previously 
demonstrated [24]. No difference was made in the interpretation of vaccine and non-vaccine serovars 
since all vaccinated dogs positive for one of the 2 vaccine serovars Icterohemorrhagiae and Canicola 
also displayed a stronger positive reaction to at least another serovar. Since the results of MAT 
serology are considered poor predictors of the infecting serovar in humans, no attempt was made to 
define the infecting serovars and only rates of seropositivity and seroconversion are reported [33]. 
A point-of-care canine IgM ELISA (Test-it

 Canine Leptospira Lateral Flow Rapid Test, Life 
Assay Diagnostics, Cape Town, South Africa) was performed at presentation [34]. Because of possible 
false positive results following vaccination, the test was only used in dogs not vaccinated for 
leptospirosis in the 5 months prior to presentation. 
The LipL32 nested PCR was performed by a commercial laboratory (IVD, Gesellschaft für 
Innovative Veterinärdiagnostik GmbH, Hannover, Germany) on blood, urine, kidney or liver tissue, 
depending on sample collection timing, tissue availability, and pre-referral treatment history. The 
proprietary genus-specific oligonucleotide primers included an external 519-bp product and an internal 
286-bp product and were derived from the sequence of L. interrogans strain RZ11 (GenBank  
accession No. AF181553) [24]. 
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2.3. Data and Statistical Analysis 
In 2007, availability of renal replacement therapy for small animals at our hospital changed 
markedly the treatment of dogs affected with leptospirosis. At the same time, the diagnostic workup 
was standardized to include systematic screening for the four main organ manifestations in all affected 
dogs, whenever possible. Statistical analyses dealing with organ manifestations and outcome were 
therefore performed both for the whole study population (2003–2012) and for a restricted dataset from 
the 256 cases diagnosed between 2007 and 2012. Similarly, in order to avoid case selection and 
recruitment bias, analyses of geoclimatic data were performed on the whole dataset of 298 cases as 
well as in the 278 cases originating only from the 10 main cantons affected (defined as the cantons 
with more than five cases in 10 years), and in 90 cases originating only from the canton Bern where 
the university hospital is located.  
All data were retrieved from the hospital information system, stored and organized for statistical 
procedures in Microsoft Excel, and exported for statistical analysis to commercial statistical software 
(NCSS, version 8, NCSS LLC, Kaysville, UT, USA). Numerical data were tested for normality with 
the Shapiro-Wilk W test and the Kolmogorov-Smirnov test. Since multiple sets of data were not 
normally distributed, all numerical data are presented as median and interquartile range (IQR). 
Statistical comparisons between groups of numerical data were performed with the Mann-Whitney  
U test, where appropriate, and comparisons of proportions of categorical data were performed with the 
Fisher exact test or the Chi-square test. Correlations between climatic data and case numbers were 
tested with a single linear regression analyses and reported as the coefficient of determination r
2
 and 
the P-value. However, since the cases diagnosed at the authors’ institution were not necessarily 
representative for the whole Swiss canine population, associations with geoclimatic data are purely 
descriptive, aiming at identifying the main parameters associated with case numbers.  
Univariate odds ratios for negative outcome were calculated for the organ involvements with  
a logistic regression analysis and expressed with their 95% confidence intervals. For all statistical tests, 
P-values < 0.05 were considered significant. 
3. Results and Discussion 
3.1. Results  
3.1.1. Dogs: Signalment 
During the 10 years of the study, 298 dogs were diagnosed with leptospirosis at the Veterinary 
Teaching Hospital of the Vetsuisse Faculty University of Bern and they were included in this report. 
This corresponds to an overall annual incidence rate of 5.88 diagnosed cases of leptospirosis per 
100,000 dogs per year. Median age of the affected dogs was 6.3 years (1.8–8.7), the youngest dog 
being 1.5 month old and the oldest dog 14.4 years old. Age distribution is represented in Figure 1, 
indicating 61 puppies (<1 year, 20.5%), 60 young adults (1–4 years, 20.1%), 141 middle-aged dogs  
(5–9 years, 47.3%), and 36 older dogs (>10 years, 12.1%). Compared to the normal dog population of 
the ANIS dog registration database, puppies were markedly over-represented and older dogs  
under-represented (P < 0.001).  
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Gender distribution indicated a clear over-representation of males (68.1%) compared to females 
(31.9%), in contrast to the whole canine hospital population consisting of 51.9% males and 48.1% 
females (P < 0.001) or to the ANIS dog registration database with 49.2% males and 50.8% females  
(P < 0.001). Neutering status was similar to the hospital population for males (31.0% of affected males 
were neutered, compared to 31.4% in the male hospital population; (P = 0.97)) but sexually intact 
females were markedly under-represented (28.4% in affected females compared to 47.4% in the female 
hospital population; P < 0.001).  
Two hundred and fifty-seven dogs (86.2%) were pure-bred dogs from 91 different breeds and  
41 dogs (13.8%) were mixed-breed dogs. Most dogs were from large breeds with a median body 
weight of 20.4 kg (11.0–30.0 kg).  
Figure 1. Age distribution of 298 dogs diagnosed with leptospirosis in Switzerland.  
 
Note: The number of cases is represented in blue bars, with the age classes characterized with different 
shades of blue. The red line depicts the age distribution of the whole Swiss canine population, based on the 
mandatory dog registration database (ANIS). 
3.1.2. Disease: Diagnosis, Organ Manifestations, and Outcome 
In 132 dogs (44.3%) the clinical suspicion of leptospirosis was confirmed with paired MAT 
serology, in 127 dogs (42.6%) with single MAT serology, in six dogs (2.0%) with IgM ELISA, in  
11 dogs (3.7%) with PCR, and in 22 dogs (7.4%) with histopathology. The rates of seropositivity to 
the 11 individual serovars tested are reported in Figure 2. Of the 259 dogs confirmed by MAT 
serology, 70.5% and 69.1% tested positive to the two main serovars Australis and Bratislava, 
respectively, both serovars belonging to the same serogroup Australis. An intermediate group with the 
serovars Grippotyphosa, Pomona, and Autumnalis tested positive in 33%–34% of the dogs.  
Vaccination history was available for 251 dogs (84.2%). Of these, 239 (95.2%) had been vaccinated 
against leptospirosis using a standard bivalent vaccine containing the serovars Canicola and 
Icterohaemorrhagiae in the past, and 220 (87.6%) within the last 12 months, according to the current 
recommendations for canine vaccinations. Seropositivity to these these vaccine serovars was only seen 
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in 14.4% (Icterohaemorrhagiae) and 12.3% (Canicola) of the tested dogs, with the highest titer to one 
of these two serovars observed in only three dogs not vaccinated for more than 12 months. 
Figure 2. MAT seropositivity for 11 serovars tested in 259 dogs diagnosed with 
leptospirosis in Switzerland.  
 
Notes: The results include grouped data obtained from paired sample serology (% seroconversion) in 132 
dogs and single sample serology (% dogs with titer ≥1:800) in 127 dogs, the pattern being similar for both 
groups of dogs. The serology panel included following serovars: L. interrogans serovars Australis (AUS), 
Bratislava (BRA), Autumnalis (AUT), Pomona (POM), Icterohaemorrhagiae (ICT), Canicola (CAN), Tarassovi 
(TAR), Bataviae (BAT), Sejroe (SEJ), Hardjo (HAR), and L. kirschneri serovar Grippotyphosa (GRI).  
Seventy-three dogs (24.5%) were affected by only one of the four main organ manifestations (renal, 
hepatic, pulmonary, or hemorrhagic), 130 dogs (43.6%) with two, 69 dogs (23.2%) with three, and  
26 dogs (8.7%) had all four organ systems affected. Except for one dog diagnosed with isolated liver 
manifestation, all dogs diagnosed with leptospirosis showed evidence of renal involvement (297/298, 
99.7%), with a median serum creatinine concentration of 686 µmol/L (462–977) (normal range,  
53–120 µmol/L). At presentation, 65 dogs (22.4%) had mild AKI, 132 dogs (45.5%) moderate AKI, 
and 93 dogs (32.1%) severe AKI, with oligo-anuria present in 95 dogs (31.9%). Hepatic involvement 
was seen in 104 dogs (35.4%) and it was severe in 71 of them (24.1%). Pulmonary manifestation was 
diagnosed in 203 dogs (68.8%) and DIC in 40 dogs (18.4%).  
Out of the 298 dogs diagnosed with leptospirosis, 169 (56.7%) survived to discharge, 30 (10.1%) 
died, and 99 (33.2%) were euthanized for medical and/or financial reasons. 
In 2007, introduction of a standardized diagnostic workup of new therapeutic options changed the 
perceived profile of the disease and its outcome. Organ involvement and odds ratios for survival are 
therefore described for the 256 dogs diagnosed since that time (2007–2012) and summarized in Table 1.  
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Table 1. Main organ system manifestations in 256 dogs diagnosed with leptospirosis between 
2007 and 2012 and univariate odds ratios (OR) for negative outcome (death or euthanasia).  
Organ 
Involvement 
N affected/N total % affected 
OR for  
negative outcome 
95% CI P 
Renal 255/256 99.6% n/a n/a n/a 
Serum creatinine at presentation 1.0019 1.0011–1.0027 <0.001 
Pulmonary 194/253 76.7% 3.6 1.8–7.2 <0.001 
Hepatic 66/254 26.0% 16.3 7.7–34.5 <0.001 
Hemorrhagic 38/209 18.2% 7.9 3.4–18.4 <0.001 
Note: The odds ratio for negative outcome was not calculated for renal involvement since almost all dogs 
were affected. However, the effect of the degree of renal failure on outcome was evaluated with the OR for 
the serum creatinine concentration that was positively associated with death.  
3.1.3. Geographic Distribution of the Cases  
The majority of the cases diagnosed with leptospirosis during the 10 years covered by this report 
were living in lower parts of the country as represented in Figures 3 and 4. Two hundred and nineteen 
dogs (75.5%) were originating from the bioregion Plateau (27% of the national surface area, 66% of 
the human population); 31 dogs (10.7%) from the Jura (10% of the national surface area, 23% of the 
human population); and 40 dogs (13.8%) from the Alps (63% of the national surface area, 11% of the 
human population) (Figure 4). The median altitude of the animals location was 485 m (431–567) 
above sea level, with 95% of the dogs coming from altitudes <800 m (Figure 4).  
Figure 3. Geographic representation of the origin of 298 dogs diagnosed with leptospirosis 
(2003–2012) and their localization in the three main bioregions of Switzerland. 
 
Notes: The surface area of Switzerland was divided in Jura (north-west), Plateau (centre), and Alps (south), 
according to the bioregion definition of the Swiss Federal Office for the Environment. The distribution of the 
cases diagnosed with canine leptospirosis and the distribution of the corresponding human population was as 
follows: Jura (11% of the canine cases, 23% of the human population), Plateau (75% of the canine cases, 
66% of the human population), Alps (14% of the canine cases, 11% of the human population).  
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Figure 4. Geographic representation of the origin of 298 dogs diagnosed with leptospirosis 
(2003–2012) and their relationship to the altitude.  
 
Notes: Following altitude zones are represented in this figure: white: <800 m (including 95% of the cases); 
yellow: 800–1040 m (95th–99th percentiles of the cases); and brown: >1040 m (1% of the cases). 
Two hundred and seventy-eight of 298 cases (93.3%) were originating from 10 main cantons  
(BE, VD, ZH, AG, FR, GE, SO, BL, NE, LU), from which >5 cases had been diagnosed during  
the 10 years of the study. The average annual incidence of diagnosis in these main cantons was  
6.2 cases/100,000 dogs/year (5.1–8.4). The highest peak incidence rate measured in the group of the 
main cantons was 28.1 diagnosed cases/100,000 dogs/year for canton Aargau (AG) in 2010. The 
cantonal distribution of the dogs diagnosed with leptospirosis is presented in Table 2. The distribution 
of the canine and human population and the geoclimatic characteristics possibly associated with 
disease occurrence are also presented for the 26 cantons. Altitude and yearly rainfall were lower and 
average temperature higher for the most affected cantons than for the others.  
3.1.4. Incidence and Trend over the Years 
The number of dogs diagnosed with leptospirosis at the University of Bern has been markedly 
increasing over the 10 years of the study (Figure 5), with the highest number of cases recorded in 2012 
(74/298, 24.8%), corresponding to a peak annual incidence rate of 14.3 diagnosed cases of 
leptospirosis/100,000 dogs/year for all of Switzerland. The proportionate morbidity ratio increased 
similarly from 0.96 (2003) to 23.0 (2012) cases per 1000 dogs presented to the teaching hospital for 
veterinary care. 
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Table 2. Cantonal distribution of 298 cases of canine leptospirosis and relationship to 
geoclimatic data. 
Canton 
Cases 
Annual Incidence of 
Diagnosis 
Canine 
Population 
Human 
Population 
Altitude Temperature Rainfall 
n 
Average Peak 
n × 1000 n × 1000 Average (m) °C mm/year 
n/100,000 dogs/y 
Most affected cantons (>5 cases/10y) 
BE 90 13.6 27.1 66.4 963 1198 6.1 115.6 
VD 59 9.8 21.7 60.0 672 827 8.5 100.9 
ZH 32 5.5 17.3 57.7 1308 533 9.5 97.5 
AG 25 6.4 28.1 39.1 582 476 9.7 88.3 
FR 19 8.8 18.6 21.5 263 856 8.2 96.9 
GE 14 4.9 13.9 28.7 438 419 10.9 73.9 
SO 13 6.1 14.0 21.4 250 630 9.1 95.8 
BL 9 5.0 22.0 18.1 269 521 9.7 87.3 
NE 9 7.3 24.4 12.3 170 919 7.8 106.7 
LU 8 3.9 24.4 20.5 364 777 8.3 113.7 
Median 
(IQR)  
6.2 
(5.1–8.4) 
21.9 
(17.6–24.4) 
25.1 
(20.7–53.1) 
401 
(265–649) 
704 
(524–849) 
8.8 
(8.2–9.6) 
97.2 
(90.2–105.3) 
Least affected cantons (<5 cases/10y) 
GL 2 7.9 79.0 2.6 38 1589 3.9 145.5 
SG 2 0.7 3.7 27.1 466 1000 7.5 121.2 
SZ 2 2.7 13.6 7.3 141 1082 6.6 147.8 
TG 2 1.1 5.7 17.5 238 495 9.5 83.8 
GR 1 0.7 7.5 13.4 189 2021 1.9 95.1 
NW 1 6.2 61.5 1.6 40 1077 6.3 135.4 
TI 1 0.4 3.8 26.4 329 1412 6.3 138.4 
VS 1 0.5 4.5 22.2 299 2140 1.7 109.2 
ZG 1 2.3 23.3 4.3 109 651 8.6 117.3 
AI 0 0.0 0.0 0.9 16 1126 7.2 136.1 
AR 0 0.0 0.0 4.5 53 935 7.8 126.0 
BS 0 0.0 0.0 5.0 185 522 10.9 71.6 
JU 0 0.0 0.0 8.3 70 690 8.7 101.3 
OW 0 0.0 0.0 1.8 34 1329 5.4 141.0 
SH 0 0.0 0.0 4.7 75 538 9.4 75.9 
UR 0 0.0 0.0 1.6 35 1896 2.4 134.3 
Median 
(IQR)  
0.4 
(0.0–1.4) 
3.7 
(0.0–9.0) 
4.9 
(2.4–14.4) 
92 
(40–201) 
1080 
(680–1456) 
6.9 
(5.0–8.6) 
123.6 
(99.7–136.7) 
P 
 
<0.001 0.004 <0.001 <0.001 0.02 0.03 0.04 
Correlations between numbers of cases diagnosed and average temperature or yearly rainfall were 
very weak at the country level, at the level of the 10 main cantons, or at the level of canton of Bern 
with r
2
 0.001–0.060 (temperature) and 0.044–0.150 (rainfall). A moderate correlation with climatic 
data was obtained for the number of summer days (r
2
 0.245, P < 0.001) or the number of rainy days  
(r
2
 0.376, P < 0.001). However, the numbers of winter days or freezing days and sun exposure did not 
seem to correlate with the annual case number. 
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Figure 5. Annual number of cases of canine leptospirosis diagnosed at the University of 
Bern from 2003–2012 and association with country-wide average annual temperature and 
number of rainy days. 
 
3.1.5. Seasonality and Climatic Factors 
Most cases of canine leptospirosis (274/298, 91.9%) were diagnosed during the summer–fall period 
(May–October) as shown in Figure 6. Over the 10 years of the study, only three cases (1.0%) were 
diagnosed in the first quarter of the year, as opposed to 66 (22.1%) in the second, 172 (57.7%) in the 
third, and 57 (19.1%) in the fourth quarter of the year. The months with higher incidences of 
leptospirosis were also the months with the highest average temperature and rainfall (Figure 6). 
Monthly case numbers correlated strongly with the average monthly temperature (r
2
 0.73, P < 0.001) 
and moderately with the average rainfall (r
2
 0.39, P < 0.001). 
A detailed time-frame of the case distribution by quarter is shown in Figure 7, together with 
temperature and rainfall. A moderate correlation can be observed between quarterly case numbers and 
temperature (r
2
 0.37, P < 0.001) and between quarterly case numbers and rainfall (r
2
 0.30, P < 0.001) 
for the 10 main cantons. Similar results were obtained when analyzing these data for the whole country 
or when restricting the data to the canton Bern only, in order to minimize recruitment bias.  
3.2. Discussion  
This study presents an overview on 298 cases of clinical canine leptospirosis in Switzerland over  
a 10-year period. The results indicate a significantly increasing incidence during that time. With  
74 cases, the peak year 2012 stands in striking contrast to an earlier study conducted at the same 
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institution, reporting 11 cases during the five-year period 1992–1996 [35]. These data support the 
hypothesis that canine leptospirosis is a re-emerging disease in this area of temperate climate. 
Figure 6. Seasonal distribution of 298 cases of canine leptospirosis in Switzerland and 
corresponding average monthly temperature and rainfall. 
 
Figure 7. Distribution of 256 cases of leptospirosis by quarters for the 10 mainly affected 
cantons (2003–2012) and corresponding temperature and rainfall curves. 
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Describing cases from a single institution, the present study does not pretend to represent uniformly 
the whole Swiss canine population. Furthermore, not all dogs with leptospirosis are seen by  
a veterinarian or referred to a specialist for advanced care and increasing awareness for the disease 
may have biased the yearly incidence rates of diagnosed cases. However, since yearly case numbers 
and correlations with geoclimatic parameters yielded similar results when restricted to the 
subpopulations of the most represented cantons or solely to the canton of the authors’ institution, the 
authors feel confident that a possible geographic recruitment bias remained minimal and did not affect 
the main findings of the study. Additionally, the diagnostic effort and the inclusion criteria defined in 
the previous study [35] were very similar to the ones used for this report, indicating a true increase of 
the incidence of canine leptospirosis in Switzerland.  
The seasonal pattern of infections with predominance of the summer and autumn months are in 
agreement with previous studies [36–38]. The correlations observed between temperature, rainfall, and 
monthly case numbers support a role for climatic conditions, likely facilitating survival and 
development of both leptospires and their rodent vectors in the environment. Changes in these climatic 
conditions (e.g., due to global warming) could therefore potentially lead to an increase in the yearly 
incidence of leptospirosis. However, environmental factors have not changed drastically over the past 
10 years and correlations with yearly incidence rates were weak for most climatic parameters tested. 
The marked increase in the incidence of canine leptospirosis is therefore only partially to be explained 
with climatic variations. Other factors including changes in population size, activity, and habitat of 
various host species favoring survival and/or transmission of leptospires must therefore exist. In the 
rural areas of Berlin, a dramatically growing population of wild boars harboring leptospires has been 
described simultaneously with an increasing incidence of canine leptospirosis [30]. A similar 
observation was made in another area of Germany, when an unusually mild winter in 2006/2007 
favored the growth of the vole population, leading to a resurgence of human leptospirosis [39]. 
Our results show that canine leptospirosis is especially prevalent in certain areas of Switzerland, 
with only a small number of cases from the mountain bioregions of the Jura and the Alps. In these 
bioregions, a harsher climate with lower temperatures year round hinders survival and/or proliferation 
of shed leptospires and influences the population of wildlife hosts. On the Plateau bioregion, infections 
seem to be concentrated around lakes and urban sites, although this densely built area does not really 
allow these two parameters to be analyzed more closely. The spread into urban areas has previously 
been reported in Europe and USA and it may be related to the proliferation of rodents as well as the 
urbanization of previously wild areas [39].  
The dog is the natural reservoir for serovar Canicola but the occurrence of this serovar has declined 
in Europe since dogs are vaccinated routinely [40]. Most infections currently documented in dogs are 
from other (incidental) serovars, with differences between geographic areas [21]. European reports 
describe mostly the serovars Australis, Grippotyphosa, and occasionally Pomona [24]. During the 
whole duration of the study, only bivalent vaccines against serovars Canicola and Icterohaemorrhagiae 
have been available in Switzerland, providing therefore inadequate protection against the encountered 
serovars, as evidenced with the high rate of vaccine coverage in the affected dogs from the current 
study. However, high titers against serovars Australis and Pomona were already described 15 years 
ago in Switzerland at the authors’ institution, making a recent serovar shift the principal cause of 
increasing incidence of leptospirosis very unlikely [35]. Obviously shifts in infecting leptospires could 
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well happen at the level of strains and not of serovars. The definition of serovars being somehow 
artificial anyway, its characterization with serological data alone is imprecise [23,33].  
Clinical manifestations of canine leptospirosis are very similar to the human disease, including 
acute renal and hepatic failure, hemostatic disturbances, and an increase in pulmonary involvement 
over the last few years, closely resembling the severe pulmonary form of leptospirosis (SPFL) 
described in humans [23,31,41]. Severity of disease and organ involvement may vary, and current data 
do not support an association with the inciting serovar, although exact serovar identification based on 
culture and strain isolation have not been performed in these studies that were only based on serology 
results [36]. The high rate of SPFL found in the present study and in reports from other countries, may 
originate from a real shift of organ involvement or it could be at least partially due to increased 
awareness and diagnostic effort [30]. Rates of mortality from SPFL in human medicine are as high as 
30%–70%, similar to our findings that indicate a clear association with negative outcome [42–44]. 
In the present study, intact male dogs are overrepresented, in accordance with previous  
publications [2]. The increased risk may be explained partly by increased outdoor activity and by 
canine male specific behavior including sniffing and licking of urine, potentially favoring dog-to-dog 
transmission. A similar gender predisposition has been described in humans, where it was initially 
thought to be associated with occupational and outdoor activities [45], although recent data suggest 
that other factors including hormonal influences must be involved as well [46]. Our results further 
indicate that puppies seem to be at increased risk of leptospirosis with 20.5% of dogs in this study 
being under the age of 1 year. This may be due to overexposure to the environment during the 
socialization process or to a temporal gap in immunity. A generalized immune compromise  
(e.g., secondary to malnutrition or poor development) was however not a feature of the dogs from this 
study, where most of the young dogs were very fit until a few days prior to the presentation for 
veterinary care (data not shown).  
The precise role of the dog in the epidemiology of leptospirosis is difficult to establish and remains 
controversial [19]. It is likely that marked differences exist between areas with different geographic, 
wildlife, social, and economic features, and that the role of the dog may vary depending on these 
parameters. A close contact of many humans with dogs and their full integration in the household bring 
the potential of high exposure, particularly in industrialized countries. Detection of leptospires by PCR 
in the urine of 1.5%–8% of clinically healthy dogs can justify a role as potential reservoir and vector 
for the canine species [12,14]. 
Increasing numbers of human cases of leptospirosis have been reported from non-tropical countries 
including Germany and Ireland [47], paralleling an increasing number of diseased dogs in  
Germany [48,49]. While transmission of infectious agents from the dog to humans is certainly 
possible, most of the evidence for the role of the dog as a vector of infection remains indirect and 
based on similarities in seroreactivity patterns [13,19].  
Exposure of veterinary professionals has been evaluated in several studies indicating seroreactivity 
in 2.5% of veterinarians treating small, large, and exotic animals [50]. Another study performed at the 
authors’ institution could however not show any evidence of exposure in owners of sick dogs and in 
veterinary staff treating a high caseload of dogs with leptospirosis, indicating that direct transmission 
of leptospirosis from clinically affected dogs is uncommon when precautionary measures are taken and 
standard hygiene protocols are respected [18]. To the authors’ best knowledge, none of the human 
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caretakers of the 298 clinically sick dogs from the present study were infected, despite repeated and 
sometimes very close physical contact. However, since uncomplicated and asymptomatic courses of 
disease cannot be excluded, the exact role of the dog as a zoonotic vector in Switzerland cannot be 
further defined based on these data. 
On the other side, this report shows that dogs suffer from clinical manifestations similar to the ones 
described in humans and that canine leptospirosis is associated with a high mortality rate despite a high 
level of care. A role of model for the human disease may therefore be postulated and it may be useful 
for investigations into the pathogenesis and the therapy of uncommon or new manifestations such as 
the SPFL, for example [31,51].  
Although not directly comparable, the high incidence rates of diagnosed cases described in the 
present study (median of peak cantonal incidence rate of 22 diagnosed cases/100,000 dogs/year) are 
closer to incidence rates described for humans in tropical regions or during epidemic outbreaks 
following natural disasters. The calculated incidence rates are certainly underestimating the true 
incidence and represent only the tip of the iceberg. Our hospital treats only approximately half of the 
severely affected dogs nationwide and the number of dogs not requiring referral to a specialized 
institution is even more difficult to estimate.  
The high incidence rates from the present study stand however in marked contrast with a low 
incidence in humans (0.05 cases/100,000 humans/year in Switzerland, 1988–1998) [15,52]; a  
non-existing problem in food animals under official control and mandatory reporting; and no obvious 
evidence of a severe problem in wild animal species. Newer data or trends in the annual incidence of 
human cases are unfortunately not available for Switzerland and the disease has been reported to be 
likely underdiagnosed in this country [52]. It is also likely that higher levels of disease are needed for it 
to become apparent clinically in some wildlife species. Other indicators of a possible latent problem 
have however been reported, including a high prevalence of renal carriers in rodents of the city of 
Zurich and the recent description of a few affected beavers deceased in the waters of the  
Plateau [53,54]. In this area, the dog seems therefore to be the only obvious evidence for the presence 
of leptospirosis and these canine data indicate that leptospires are more widespread than commonly 
thought in Europe. This report should thus increase awareness of this “neglected tropical disease” in 
non-tropical areas, and contribute to a more realistic and evidence-based risk estimation in all animal 
species and in humans.  
4. Conclusions  
The results of this study indicate that canine leptospirosis is a re-emerging disease in the temperate 
climate zone of Switzerland with increasing incidence over the past few years, independent of 
environmental factors. Canine leptospirosis has similar clinical manifestations and outcomes as in 
humans for which it may be a model. Next to being a potential vector of disease, the dog may be 
indicative of high infectious pressure from the environment. Increasing numbers of active infections in 
our canine population should therefore heighten the awareness of the disease for humans and other 
animal species and support early diagnostic efforts and therapeutic intervention. 
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